<

All departments to send force supply and demand

  On February 9, the State Council issued the Opinions on Further Reforming and Perfecting the Policy on the Use of Drugs for Production and Circulation. In order to improve the quality of medicines, promote the structural adjustment of the pharmaceutical industry, rectify the circulation of medicines, promote the reform of the drug circulation system, The reform and adjustment of the interests of the driving mechanism, etc., a clear drug production, circulation, the use of the whole chain of related policies, some of the New Deal will be the pharmaceutical manufacturers, distributors, medical institutions and medical staff have a direct impact.
  "Opinions" clear, speed up the quality and efficacy of generic drugs has been listed on the evaluation, to speed up the common name to develop health insurance payment standards, improve the shortage of drugs, low-cost drug monitoring and early warning and grading response mechanism to promote the realization of patented drugs and patented drugs In China the selling price is not higher than the country of origin or neighboring countries and regions comparable prices. Food and drug regulatory authorities to initiate the establishment of drug price information can be traced back to the mechanism, and drug centralized procurement platform, medical insurance payment audit platform interoperability, and strengthen the sharing of relevant tax data. Strengthen the competition of inadequate pharmaceutical factory (port) price, the actual purchase price monitoring, abnormal price variation or price variance with the same species is too large drugs, timely research and analysis, if necessary, opening up the price of special investigation.
  "Opinions" requirements, food and drug supervision, health and family planning, taxation, public security departments should regularly carry out joint inspection, crack down on rental certificates, illegal channels of purchase and sale of drugs, price fraud, price monopoly and forgery and other illegal activities. Food and drug regulatory authorities to strengthen the management of the medical representatives, the establishment of registration system, medical representatives can only engage in academic promotion, technical advice and other activities, shall not assume the task of drug sales, credited to personal credit records.
  "Opinions" provides for the optimization and adjustment of essential drugs directory, public hospitals should be fully equipped with priority to the use of essential drugs. Medical institutions should use the procurement of drugs as an important content of public hospital, focusing on monitoring of antibiotics, adjuvant drugs, nutritional use of drugs. Health and family planning departments on the rational use of drugs in medical institutions to assess the rankings, assessment results should be assessed with the president, performance pay, etc. linked to the approved.
  "Opinions" that the health and family planning departments at all levels should be reasonable to determine and quantify the regional growth rate of medical expenses, the medical expenses control and public hospital financial subsidies, assessment gifted, performance pay approved, the president hired, Hospital, the suspension of its rating accreditation, additional bed approval and large equipment with the qualifications, as the case of reduction or cancellation of financial subsidies, project arrangements, and held the corresponding responsibility of the hospital president.

  "Opinions" stressed that give full play to all types of medical insurance on medical service behavior, control and supervision of the role of medical expenses, explore the establishment of medical insurance designated medical institutions credit rating management and blacklist management system. All localities in the promotion of medical service price reform, pharmacists to carry out prescription review and adjustment, clinical medication guidance, standardize drug use, combined with actual co-ordination considerations, explore reasonable compensation approach, and do with health insurance policy convergence.